Testing offers CBR families the opportunity to proactively seek additional information about their child’s health
TRUMBULL, Conn. and EL MONTE, Calif. — CooperSurgical®, a global leader in fertility and women’s health, and Fulgent Genetics, Inc. (NASDAQ: FLGT), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced that they have partnered to offer families of Cord Blood Registry® (CBR®) exclusive newborn genetic screening panels. [Read more…]